Startups channel feed – Endpoints News

Startups channel feed

Nuvig raises $161M as it prepares for Phase 2 study in hot autoimmune field

5 months ago

GSK partners with Rgenta on RNA-targeted small molecules for oncology, other areas

5 months ago

Ro’s weight loss business more than doubled in the last year. Now it’s trying to prove its program works

5 months ago

Dewpoint partners its ALS program, eyes JPM to raise a Series D

5 months ago

On heels of MariTide data, Danish obesity biotech discloses €80M Series A

5 months ago

After deal about-face and a spinout, Maze assembles $115M Series D

5 months ago

Gilead makes another ADC move, inking up to $415M pact with Tubulis

5 months ago

Acadia snaps up an essential tremor drug after field's summer setbacks

5 months ago

Food allergy biotech Alladapt closes after Phase 3 talks with FDA

6 months ago

Gilead buys experimental HIV vaccines from a small Barcelona biotech

6 months ago

ADC biotech Adcendo nabs $135M Series B as it enters the clinic

6 months ago

Microsoft-backed Enveda raises $130M for drugs in I&I, obesity and other areas

6 months ago

Venrock adds $500M to healthcare investing strategy after outlining 10th fund in January

6 months ago

Carolyn Bertozzi’s latest biotech debuts with $30M seed round and a sugary spin on immunotherapy

6 months ago

Exclusive: Former Pfizer commercial chief Angela Hwang to join Flagship

6 months ago

Pfizer partners with two more Flagship biotechs on obesity, cancer

6 months ago

Former NCI director teams up with serial entrepreneur for $70M VC fund targeting 'super-early' science

6 months ago

Atlas Venture targets $450M for 14th biotech fund, the same size as its 2022 raise

6 months ago

Novartis strikes radiopharma deal with Ratio worth up to $745M

6 months ago

Exclusive: Athena Countouriotis' Avenzo taps Shanghai biotech for ADC, adds new funds

6 months ago

Scottish biotech debuts with ‘Trojan horse’ platform for cancer

6 months ago

Exclusive: Ascidian CEO Michael Ehlers leaves Apple Tree Partners for MPM BioImpact

6 months ago

Metsera raises $215M for studies of GLP-1 and amylin obesity drugs

6 months ago

Exclusive: Flagship names two CEO-partners to lead Valo Health, Apriori Bio

6 months ago

First page Previous page 5 6 789 10 11 Next page Last page